Såranalyse.dk ApS: Financial statements 2020
CVR: 32661971
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Såranalyse.dk ApS (CVR 32661971) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -8,918 and a net result of DKK -2,343 compared with DKK 3,044 the year before. Equity in the 2020 report amounted to DKK 264,119. The solvency ratio was 60.1%.
- Gross Profit
- DKK -8,918
- Profit/Loss
- DKK -2,343
- Equity
- DKK 264,119
- Total Assets
- DKK 439,649
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -9 t. | -2 t. | 264 t. | - |
| 2019 | - | -6 t. | 3 t. | 266 t. | - |
| 2018 | - | -7 t. | -9 t. | 263 t. | - |
| 2017 | - | -9 t. | -625 t. | 272 t. | - |
| 2016 | - | -6 t. | -158 t. | 897 t. | - |
Official annual report
How creditworthy is Såranalyse.dk ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Såranalyse.dk ApS has published its annual report for 2019. Gross profit came to DKK -6,262, and the net result was DKK 3,044.
About Såranalyse.dk ApS
Såranalyse.dk ApS was a Danish company of the type Anpartsselskab based in Ugerløse, founded in 2009. The company has been dissolved. The company was registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named SUSAN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -20,744 and a net result of DKK -297,616 compared with DKK -2,153 the year before. Equity in the 2025 report amounted to DKK -72,959.